HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Acute onset of bilateral visual loss during sildenafil therapy in a young infant with congenital heart disease.

Abstract
We report a case of posterior non-arteritic ischaemic optic neuropathy (NAION) causing bilateral visual loss in a 7-month-old female infant, after a therapeutic course with sildenafil, a phosphodiesterase type 5 inhibitors (PDE5i). The patient was affected by a complex cyanotic congenital heart defect and had undergone cavopulmonary anastomosis (Glenn operation) 3 months ago. After 2 months of recurring chylothorax, a course of oral sildenafil was administered, with the hypothesis that pulmonary vascular resistances were increased. Approximately 4 weeks later the acute onset of visual worsening and poor pupillary light reflex prompted the diagnosis of posterior NAION. Despite a rapid cessation of PDE5i and systemic treatment with corticosteroids, no visual recovery was noticed at 2-year follow-up. NAION has been associated with PDE5i therapy in adults, but to the best of our knowledge it is almost unheard of in children. We suggest close monitoring of visual function in children undergoing treatment with sildenafil.
AuthorsMarcella Gaffuri, Alessandra Cristofaletti, Caterina Mansoldo, Paolo Biban
JournalBMJ case reports (BMJ Case Rep) Vol. 2014 (Jun 03 2014) ISSN: 1757-790X [Electronic] England
PMID24895393 (Publication Type: Case Reports, Journal Article)
Copyright2014 BMJ Publishing Group Ltd.
Chemical References
  • Phosphodiesterase 5 Inhibitors
  • Piperazines
  • Purines
  • Sulfones
  • Sildenafil Citrate
Topics
  • Acute Disease
  • Blindness (chemically induced, diagnosis)
  • Diagnosis, Differential
  • Female
  • Follow-Up Studies
  • Heart Defects, Congenital (drug therapy)
  • Humans
  • Infant
  • Magnetic Resonance Imaging
  • Optic Neuropathy, Ischemic (complications, diagnosis, physiopathology)
  • Phosphodiesterase 5 Inhibitors (adverse effects, therapeutic use)
  • Piperazines (adverse effects, therapeutic use)
  • Purines (adverse effects, therapeutic use)
  • Sildenafil Citrate
  • Sulfones (adverse effects, therapeutic use)
  • Tomography, X-Ray Computed
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: